Inventor · disambiguated record
Christina B. Madsen-Duggan
Also filed as: MADSEN-DUGGAN CHRISTINA · MADSEN-DUGGAN CHRISTINA B
19 granted patents·5 pending applications·50 citations·filing 2003–2025
91Inventor score
Files withMERCK SHARP & DOHME13DEBENHAM JOHN S4CLEMENTS MATTHEW J3BRISTOL MYERS SQUIBB CO1CAI JIAQIANG1
Top patents by PatentIndex Score
24 records- 0188US7999107B2Substituted pyrano[2,3-B]pyridine derivatives as cannabinoid-1 receptor modulatorsMERCK SHARP & DOHME·Filed 2008·Granted Aug 16, 2011·13 cites·16 claims
- 0287US10183981B2Insulin receptor partial agonistsMERCK SHARP & DOHME·Filed 2018·Granted Jan 22, 2019·5 cites·6 claims
- 0383US8372863B2Tetrahydro-1H-pyrrolo fused pyridonesMERCK SHARP & DOHME·Filed 2009·Granted Feb 12, 2013·4 cites·14 claims
- 0482US10017556B2Insulin receptor partial agonistsMERCK SHARP & DOHME·Filed 2015·Granted Jul 10, 2018·3 cites·10 claims
- 0581US7091216B2Substituted furo[2,3-b]pyridine derivativesMERCK & CO INC·Filed 2003·Granted Aug 15, 2006·17 cites·14 claims
- 0678US10689430B2Insulin receptor partial agonistsMERCK SHARP & DOHME·Filed 2017·Granted Jun 23, 2020·1 cites·6 claims
- 0772US10800827B2Insulin receptor partial agonistsMERCK SHARP & DOHME·Filed 2018·Granted Oct 13, 2020·0 cites·4 claims
- 0871US8445680B2Tetrahydrothieno pyridinesDEBENHAM JOHN S·Filed 2009·Granted May 21, 2013·2 cites·14 claims
- 0968US7728141B2Substituted naphthyridinone derivativesMERCK SHARP & DOHME·Filed 2004·Granted Jun 1, 2010·4 cites·8 claims
- 1066US11752128B2Benzimidazoles and indoles as taro inhibitorsMERCK SHARP & DOHME·Filed 2021·Granted Sep 12, 2023·0 cites·3 claims
- 1163US11738010B2Oxazolidinones as TarO inhibitorsMERCK SHARP & DOHME·Filed 2021·Granted Aug 29, 2023·0 cites·14 claims
- 1263US8815865B2Substituted 4-hydroxypyrimidine-5-carboxamidesCLEMENTS MATTHEW J·Filed 2010·Granted Aug 26, 2014·1 cites·4 claims
- 1359US11141410B2Oxazolidinones as taro inhibitorsMERCK SHARP & DOHME·Filed 2016·Granted Oct 12, 2021·0 cites·14 claims
- 1457US11141403B2Benzimidazoles and indoles as taro inhibitorsMERCK SHARP & DOHME·Filed 2016·Granted Oct 12, 2021·0 cites·1 claims
- 1557US2023310551A1Insulin receptor partial agonistsMERCK SHARP & DOHME LLC·Filed 2021·Application pending·0 cites
- 1649US2025346577A1Processes for the preparation of substituted 3-((3-aminophenyl)amino)piperidine-2,6-dione compoundsBRISTOL MYERS SQUIBB CO·Filed 2025·Application pending·0 cites
- 1746US8278304B2Substituted 4-hydroxypyrimidine-5-carboxamidesCLEMENTS MATTHEW J·Filed 2009·Granted Oct 2, 2012·0 cites·17 claims
- 1844US2010029697A1Substituted pyrido[3,2-e][1,2,4]triazolo[4,3-c]pyrimidine derivatives as cannabinoid-1 receptor modulatorsDEBENHAM JOHN S·Filed 2008·Application pending·0 cites
- 1944US2010063032A1Substituted pyrido[2,3-d]pyrimidine derivatives as cannabinoid-1 receptor modulatorsDEBENHAM JOHN S·Filed 2008·Application pending·0 cites
- 2041US10000501B2Inhibitors of HIF prolyl hydroxylaseMERCK SHARP & DOHME·Filed 2015·Granted Jun 19, 2018·0 cites·5 claims
- 2139US2008269279A1Substituted furo[2,3-B] pyridine derivatives as cannabinoid-1 receptor modulatorsCLEMENTS MATTHEW J·Filed 2008·Application pending·0 cites
- 2237US9006268B2Prolylcarboxypeptidase inhibitorsDEBENHAM JOHN S·Filed 2011·Granted Apr 14, 2015·0 cites·9 claims
- 2337US8372857B2Substituted 4-hydroxypyrimidine-5-carboxamidesMERCK SHARP & DOHME·Filed 2010·Granted Feb 12, 2013·0 cites·10 claims
- 2436US10208060B2Inhibitors of HIF prolyl hydroxylaseCAI JIAQIANG·Filed 2015·Granted Feb 19, 2019·0 cites·3 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →